info@birdgroup.be

Login

Research papers

Journal of Crohn's and Colitis, 27 January 2023, jjad015
Patient reported outcomes and disability are associated with histological disease activity in patients with ulcerative colitis: results from the APOLLO study

The Lancet Gastroenterology and Hepatology, February 01, 2023
Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA)

Nat Rev Gastroenterol Hepatol . OCTOBER 2022
Dietary management of adults with IBD - the emerging role of dietary therapy

Lancet Gastroenterol Hepatol . 2022 OCTOBER 2022
Etrolizumab as induction and maintenance therapy in patients with moderately to severely active Crohn's disease (BERGAMOT): a randomised, placebo-controlled, double-blind, phase 3 trial

JCC Journal of Crohn's and Colitis, JJAC115, 25 AUGUST 2022
European Crohn’s and Colitis Guidelines on Sexuality, Fertility, Pregnancy, and Lactation

The Lancet Gastroenterology & Hepatology: VOLUME 7, ISSUE 7, P617-626, JULY 01, 2022
Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy in the treatment of perianal fistulas in Crohn's disease (PISA-II): a patient preference randomised trial

Gastroenterology April 2022: Volume 162, Issue 5
Introduction to the IBD special edition

N Engl J Med 2021; 385:1280-1291
Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis

‹
1
2
3
4